Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort study
Background: Mycobacterium avium complex lung disease (MAC-LD) is a chronic, progressive, potentially life-threatening infection. Some cases are refractory to standard guideline-based therapy (GBT), and sputum cultures are persistently positive for acid-fast bacilli. Although an early identification...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-04-01
|
| Series: | Therapeutic Advances in Infectious Disease |
| Online Access: | https://doi.org/10.1177/20499361251331676 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850143402495049728 |
|---|---|
| author | Takahiko Saito Yuya Aono Masato Kono Masaki Ishige Takuma Sugiura Misato Higasa Fumiya Nihashi Mineo Katsumata Hideki Miwa Yoshihiro Miki Dai Hashimoto |
| author_facet | Takahiko Saito Yuya Aono Masato Kono Masaki Ishige Takuma Sugiura Misato Higasa Fumiya Nihashi Mineo Katsumata Hideki Miwa Yoshihiro Miki Dai Hashimoto |
| author_sort | Takahiko Saito |
| collection | DOAJ |
| description | Background: Mycobacterium avium complex lung disease (MAC-LD) is a chronic, progressive, potentially life-threatening infection. Some cases are refractory to standard guideline-based therapy (GBT), and sputum cultures are persistently positive for acid-fast bacilli. Although an early identification of treatment-refractory MAC-LD is crucial, its risk factors remain unknown. Objectives: We aimed to identify the risk factors for refractory MAC-LD in response to initial GBT. Design: A retrospective single-center study was conducted involving consecutive patients with MAC-LD who were diagnosed between 2006 and 2024 and received initial GBT. Methods: Refractory MAC-LD was defined as sputum culture positivity at least 6 months after the initial GBT. Prognostic factors were identified using Cox proportional hazards analysis, and risk factors for refractory MAC-LD were examined using logistic regression analysis. Results: Of the 201 patients with definite MAC-LD, 35 (17.4%) had refractory MAC-LD. Patients with refractory MAC-LD had a significantly lower body mass index (BMI), more cavitary lesions on high-resolution computed tomography (HRCT), and higher mortality (log-rank test, p = 0.006) compared to those with non-refractory MAC-LD. A multivariate analysis adjusted for age and sex showed that refractory MAC-LD (adjusted hazard ratio (HR): 2.76; 95% confidence interval (CI): 1.10–6.95; p = 0.030) and cavitary lesions on HRCT (adjusted HR: 2.77; 95% CI: 1.34–5.70; p = 0.005) were significantly associated with all-cause mortality. In addition, a multivariate analysis revealed that lower BMI (odds ratio (OR): 0.68; 95% CI: 0.55–0.85; p < 0.001) and cavitary lesions on HRCT (OR: 2.52; 95% CI: 1.15–5.50; p = 0.020) were independent risk factors of refractory MAC-LD. Conclusion: Low BMI and cavitary lesions on HRCT are risk factors for refractory MAC-LD. |
| format | Article |
| id | doaj-art-959e25e54e944b1e89c1107fa06d6dcc |
| institution | OA Journals |
| issn | 2049-937X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Infectious Disease |
| spelling | doaj-art-959e25e54e944b1e89c1107fa06d6dcc2025-08-20T02:28:42ZengSAGE PublishingTherapeutic Advances in Infectious Disease2049-937X2025-04-011210.1177/20499361251331676Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort studyTakahiko SaitoYuya AonoMasato KonoMasaki IshigeTakuma SugiuraMisato HigasaFumiya NihashiMineo KatsumataHideki MiwaYoshihiro MikiDai HashimotoBackground: Mycobacterium avium complex lung disease (MAC-LD) is a chronic, progressive, potentially life-threatening infection. Some cases are refractory to standard guideline-based therapy (GBT), and sputum cultures are persistently positive for acid-fast bacilli. Although an early identification of treatment-refractory MAC-LD is crucial, its risk factors remain unknown. Objectives: We aimed to identify the risk factors for refractory MAC-LD in response to initial GBT. Design: A retrospective single-center study was conducted involving consecutive patients with MAC-LD who were diagnosed between 2006 and 2024 and received initial GBT. Methods: Refractory MAC-LD was defined as sputum culture positivity at least 6 months after the initial GBT. Prognostic factors were identified using Cox proportional hazards analysis, and risk factors for refractory MAC-LD were examined using logistic regression analysis. Results: Of the 201 patients with definite MAC-LD, 35 (17.4%) had refractory MAC-LD. Patients with refractory MAC-LD had a significantly lower body mass index (BMI), more cavitary lesions on high-resolution computed tomography (HRCT), and higher mortality (log-rank test, p = 0.006) compared to those with non-refractory MAC-LD. A multivariate analysis adjusted for age and sex showed that refractory MAC-LD (adjusted hazard ratio (HR): 2.76; 95% confidence interval (CI): 1.10–6.95; p = 0.030) and cavitary lesions on HRCT (adjusted HR: 2.77; 95% CI: 1.34–5.70; p = 0.005) were significantly associated with all-cause mortality. In addition, a multivariate analysis revealed that lower BMI (odds ratio (OR): 0.68; 95% CI: 0.55–0.85; p < 0.001) and cavitary lesions on HRCT (OR: 2.52; 95% CI: 1.15–5.50; p = 0.020) were independent risk factors of refractory MAC-LD. Conclusion: Low BMI and cavitary lesions on HRCT are risk factors for refractory MAC-LD.https://doi.org/10.1177/20499361251331676 |
| spellingShingle | Takahiko Saito Yuya Aono Masato Kono Masaki Ishige Takuma Sugiura Misato Higasa Fumiya Nihashi Mineo Katsumata Hideki Miwa Yoshihiro Miki Dai Hashimoto Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort study Therapeutic Advances in Infectious Disease |
| title | Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort study |
| title_full | Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort study |
| title_fullStr | Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort study |
| title_full_unstemmed | Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort study |
| title_short | Predictive risk factors of treatment-refractory complex lung disease: a single-center retrospective cohort study |
| title_sort | predictive risk factors of treatment refractory complex lung disease a single center retrospective cohort study |
| url | https://doi.org/10.1177/20499361251331676 |
| work_keys_str_mv | AT takahikosaito predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT yuyaaono predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT masatokono predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT masakiishige predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT takumasugiura predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT misatohigasa predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT fumiyanihashi predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT mineokatsumata predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT hidekimiwa predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT yoshihiromiki predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy AT daihashimoto predictiveriskfactorsoftreatmentrefractorycomplexlungdiseaseasinglecenterretrospectivecohortstudy |